Monitor for future ATM sales announcements, which will signal immediate dilution and potential downward pressure on the stock price. The resale filing increases the potential supply of shares in the market, which could weigh on the stock, especially if selling stockholders are active. The termination of the Jefferies agreement and switch to TD Securities is a routine administrative change.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Feb 26 $95.03entry
- T+1 · 9mo ago −3.87%α −3.42% · $91.35
- T+5 · 9mo ago −12.11%α −10.98% · $83.52
- T+20 · 8mo ago −15.63%α −9.22% · $80.18
- T+60 · 6mo ago −15.17%α −22.92% · $80.61
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Kymera Therapeutics entered into a $500 million at-the-market (ATM) equity offering agreement with TD Securities (USA) LLC, terminated its prior ATM agreement with Jefferies LLC, and filed a resale prospectus supplement for up to 31.4 million shares held by certain selling stockholders. The ATM program allows Kymera to raise capital opportunistically, while the resale filing enables passive selling by existing investors without Kymera receiving proceeds.
Key Financial Metrics
Key Facts
- Entered into a $500 million at-the-market (ATM) equity offering agreement with TD Securities (USA) LLC.
- Terminated the prior Open Market Sale Agreement with Jefferies LLC.
- Filed a resale prospectus supplement for up to 18.8 million common shares and 12.6 million warrant shares held by selling stockholders.
- The ATM program allows Kymera to sell shares from time to time at its discretion, with TD Securities acting as sales agent for a commission of up to 3.0%.
- Kymera will not receive any proceeds from the resale of shares by the selling stockholders.
Financial Impact
Up to $500 million in potential gross proceeds for Kymera from the ATM offering; no proceeds to Kymera from the resale of up to 31.4 million shares by selling stockholders.
Risk Factors
- Dilution from future ATM sales could pressure the stock price.
- Increased share supply from the resale of up to 31.4 million shares by selling stockholders could create downward pressure on the stock price.
- Market perception of the ATM program as a sign of near-term funding needs could be negative.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-073561 |
| Document: d114045d8k.htm | 0001193125-26-073561 |
| Document: d114045dex51.htm | 0001193125-26-073561 |
| Document: d114045dex52.htm | 0001193125-26-073561 |
| Document: 0001193125-26-073561-index-headers.html | 0001193125-26-073561 |
| Document: 0001193125-26-073561-index.html | 0001193125-26-073561 |
| Document: 0001193125-26-073561.txt | 0001193125-26-073561 |
Track record
37 reports on KYMR
7 of 12 bullish or bearish reports moved the stock their way by T+20. Best: +60.99% at T+60 after the Jun 8, 2026 report. 9 of 14 went positive at some point.
Filters
- Nov 2, 202614d ago Institutional Cluster Neutral 3/10 Entry $127.09 Now $125.85 −0.98% settles Dec 2
- Oct 29, 202618d ago 8-K Neutral 5/10 No price data
- Oct 29, 202618d ago Press Release Bearish 5/10 Entry $122.60 Now $125.85 −2.65% settles Nov 27
- Oct 28, 202619d ago Press Release Neutral 5/10 Entry $122.60 Now $125.85 +2.65% settles Nov 27
- Oct 27, 202620d ago Institutional Cluster Bullish 4/10 Entry $122.51 Now $125.85 +2.73% settles Nov 25
- Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $122.51 Now $125.85 +2.73% settles Nov 25
- Oct 22, 202625d ago Press Release Neutral 1/10 Entry $110.85 Now $125.85 +13.53% settles Nov 20
- Aug 5, 202614w ago 8-K Bullish 6/10 Entry $105.48 to $118.63 Now $125.85 +19.31% ▲ +12.47% +13.07% vs SPY
- Jul 7, 202618w ago Insider Cluster Bearish 5/10 Entry $114.16 to $105.48 Now $125.85 −10.24% ▲ +7.60% +10.88% vs SPY
- Jul 2, 202619w ago Insider Cluster Bearish 5/10 Entry $114.76 to $100.31 Now $125.85 −9.66% ▲ +12.59% +13.44% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers